The Marqués de Valdecilla Research Institute (IDIVAL) has allocated €465,000 this year to support the activity of the 30 research groups that make up the institute. This amount represents a significant increase compared to previous calls and is part of the Support program, which provides backing for the development of activities by IDIVAL’s research groups. The program is one of the main pillars of the 2025 regional Biosanitary Research Promotion Programs Call.
The aim of this program is to acknowledge and enhance the scientific production of IDIVAL-affiliated groups by providing funding based on the results and research activity achieved throughout the year. The funds awarded help cover the groups’ operational expenses and the hiring of personnel to support the development of projects.
The allocation of these grants is determined by various activity indicators, including:
Indexed scientific publications
External funding obtained and managed through IDIVAL
Patent development
Supervision of doctoral theses
IDIVAL, accredited by the Carlos III Health Institute, promotes and develops research and innovation in the biosanitary field of Cantabria, with the Marqués de Valdecilla University Hospital as its main hub.
Each year, IDIVAL launches various support programs and competitive calls to fund research groups and drive the development of research and innovation projects by healthcare professionals within Cantabria’s public health system. In 2025, the total investment in these programs will exceed €2 million — a record figure that reflects the institution’s firm commitment to strengthening research capacity and health innovation in the region.
Since its launch in 2014, the Support program has allocated over €3.9 million to fund the activity of IDIVAL’s research groups. This support not only recognizes the achievements attained but also makes it possible to consolidate research lines, attract talent, and enhance the national and international presence of biosanitary research in Cantabria.
IDIVAL’s research groups are the driving force behind biomedical scientific output in the region, actively contributing to the advancement of knowledge and the development of innovative solutions to improve population health.
See the funding resolution and the allocation awarded to each group here: Resolution
